Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    NCT00402168
Show Display Options
Rank Status Study
1 Completed A Study of BMS-224818 (Belatacept) in Patients Who Have Undergone a Kidney Transplant and Are Currently on Stable Cyclosporine or Tacrolimus Regimen With or Without Corticosteroids
Condition: Renal Transplant
Interventions: Drug: Belatacept;   Drug: Cyclosporine A;   Drug: Tacrolimus

Study has passed its completion date and status has not been verified in more than two years.